Search Results 841-850 of 21369 for anti-TNF drugs

  1. Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer - Mayo Clinic

    Drugs used in chemotherapy ... TNF] agents) within 2 weeks prior to cycle 1, day 1: ... A stable regimen of highly active anti-retroviral therapy (HAART); ...

  2. Lamotrigine (Oral Route) Proper Use - Mayo Clinic

    Keep using all of your seizure medicines unless your doctor tells you to stop. Dosing. The dose of this medicine will be different for different patients.

  3. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

    History of systemic anti-cancer therapy (e.g., chemotherapy, targeted therapy) ... therapy for treatment of metastatic disease. ... TNF] factor agents) within 14 ...

  4. First Efficacy Study of Investigational Antiviral Therapy for COVID-19 Infection in Patients with IBD - Mayo Clinic News Network

    In a new study, Mayo Clinic in Florida researchers and collaborators have found that the antiviral medication Paxlovid reduces the risk of hospitalization ...

  5. Gentamicin (Otic Route) Precautions - Mayo Clinic

    Precautions. Drug information provided by: Merative, Micromedex®. If your symptoms do not improve within a few days, or if they become worse, ...

  6. Immune Globulin (Intramuscular Route, Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Immune globulin injection belongs to a group of medicines known as immunizing agents. ... Drugs & Supplements; Immune Globulin (Intramuscular Route, Intravenous ...

  7. Ketoconazole (Topical Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Extina; Ketodan Kit; Kuric; Nizoral; Nizoral ...

  8. Ertugliflozin And Metformin (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. Reslizumab (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  10. Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or Metastatic Melanoma (CheckMate 218) - Mayo Clinic

    Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or ...